TP53 and cancer: RG7112 shows good selectivity over mutated p53 cancer cells (MTT IC50 = 5.7–20.3 μM), and it is able to activate the p53 signaling pathway in wild-type p53 cells, leading to cell cycle arrest and apoptosis.